CMB 4.76% 40.0¢ cambium bio limited

Ann: US Patent for Sygenus, page-18

  1. 18 Posts.
    lightbulb Created with Sketch. 4
    38 Million market cap for a company with 27million earnings pathway over the next 3 years. Company is derisked and imo should be multiples of current share price. Appears nothing available in size to buy so wait for the re rate. AIMO.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.